Stratification of Pediatric Heart Failure on the Basis of Neurohormonal and Cardiac Autonomic Nervous Activities in Patients with Congenital Heart Disease

Circulation

Volumn 108, Issue 19, 2003, Pages 2368-2376

  Ohuchi, Hideo ^a   Takasugi, Hisashi ^a   Ohashi, Hiroyuki ^a   Okada, Yoko ^a   Yamada, Osamu ^a   Ono, Yasuo ^a   Yagihara, Toshikatsu ^a   Echigo, Shigeyuki ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Heart defects, congenital; Heart failure; Hormones; Nervous system, autonomic

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR; NEUROHORMONE;

ADULT; ARTICLE; AUTONOMIC NERVOUS SYSTEM; CARDIOMYOPATHY; CONGENITAL HEART DISEASE; CONTROLLED STUDY; HEART EJECTION FRACTION; HEART FAILURE; HEART RATE VARIABILITY; HEART SURGERY; HEMODYNAMICS; HUMAN; MAJOR CLINICAL STUDY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; VITAL CAPACITY;

ADOLESCENT; ADULT; ATRIAL NATRIURETIC FACTOR; BAROREFLEX; CARDIOMYOPATHY, DILATED; CHILD; CHILD, PRESCHOOL; EPINEPHRINE; FORCED EXPIRATORY VOLUME; HEART; HEART DEFECTS, CONGENITAL; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; INFANT; NATRIURETIC PEPTIDE, BRAIN; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REFLEX, ABNORMAL; RENIN; SEVERITY OF ILLNESS INDEX; VITAL CAPACITY;

EID: 0242525742     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.0000101681.27911.FA     Document Type: Article

References (28)

1. Auslender M. Pathophysiology of pediatric heart failure. Prog Pediatr Cardiol. 2000;11:175-184.
2. Ohuchi H, Suzuki H, Toyohara K, et al. Abnormal cardiac autonomic nervous activity after right ventricular outflow tract reconstruction. Circulation. 2000;102:2732-2738.
3. Ohuchi H, Hasegawa S, Yasuda K, et al. Severely impaired cardiac autonomic nervous activity after the Fontan operation. Circulation. 2001 104:1513-1518.
4. Bolger AP, Sharma R, Li W, et al. Neurohormonal activation and the chronic heart failure syndrome in adult with congenital heart disease. Circulation. 2002;106:92-99.
5. Francs GS, Benedict C, Johnstone DE, et al. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a substudy of the Study Of Left Ventricular Dysfunction (SOLVD). Circulation. 1990;82:1724-1729.
6. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med. 1984;311:819-823.
7. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with congestive heart failure. Circulation. 2002;105:2392-2397.
8. La Rovere MT, Bigger JT Jr, Marcus FI, et al. Baroreflex sensitivity and heart rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflex After Myocardial Infarction) Investigators. Lancet. 1998;351:478-484.
9. Blichick KC, Fetics B, Djoukeng R, et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs' Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol. 2002;90:24-28.
10. Ponikowski P, Francis DP, Piepoli MF, et al. Enhanced ventricular response to exercise in patients with congestive heart failure and preserved exercise tolerance: marker of abnormal cardiopulmonary reflex control and predictor of poor prognosis. Circulations. 2001;103:967-972.
11. Bruns LA, Chrisant MK, Lamour JM, et al. Carvedilol as therapy in pediatric heart failure: an initial multicenter experience. J Pediatr. 2001;138:505-511.
12. Mori K. Automated measurement of catecholamines in urine, plasma and homogenates by high-performance liquid chromatography with fluorometric detection. J Chromatogr. 1981;218:631-637.
13. Hama N, Nakao K, Mukoyama M, et al. Fundamental and clinical evaluation of "SHINORIAR ANP" human atrial natriuretic peptide IRMA kit. Clin Report. 1991;25:455-462.
14. Kono M, Yamaguchi A, Tsuji T, et al. An immunoradiometric assay for brain natriuretic peptide in human plasma. Kaku Igaku. 1993;13:2-7.
15. Ikeda I, Iinuma K, Takai M, et al. Measurement of plasma renin activity by a simple solid phase radioimmunoassay. J Clin Endocrinol Metab. 1982;54:423-428.
16. Smyth HS, Slight P, Pickering GW. Reflex regulation of arterial pressure during sleep in man. Circ Res. 1969;24:109-121.
17. Ohuchi H, Nakajima T, Kawade M, et al. Measurement and validity of the ventilatory threshold in patients with congenital heart disease. Pediatr Cardiol. 1996;17:7-14.
18. Gottlieb SS, Kukin ML, Ahern D, et al. Prognostic importance of natriuretic peptide in patients with chronic heart failure. J Am Coll Cardiol. 1989;13:1534-1539.
19. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation. 1997;96:509-516.
20. Kruger S, Graf J, Kunz D, at al. Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol. 2002;40:718-722.
21. Westendorp RG, Roos AN, van der Hoeven HG, et al. Atrial natriuretic peptide improves pulmonary gas exchange in subjects exposed to hypoxia. Am Rev Respir Dis. 1993;148:304-309.
22. Bayliss J, Norell M, Canepa-Anson R, et al. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br Heart J. 1987;57:17-22.
23. Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med. 1992;33:471-477.
24. Makikallio TH, Huikuri HV, Hintze U, et al. Fractal analysis and time- and frequency-domain measures of heart rate variability as predictors of mortality in patients with heart failure. Am J Cardiol. 2001;87:178-182.
25. Taha BH, Simon PM, Dempsey JA, et al. Respiratory sinus arrhythmia in humans: an obligatory role for vagal feedback from the lung. J Appl Physiol. 1995;78:638-645.
26. Goso Y, Asanoi H, Ishise H, et al. Respiratory modulation of muscle sympathetic nerve activity in patients with chronic heart failure. Circulation. 2001;104:418-423.
27. Gitt AK, Wasserman K, Kilkowski C, et al. Exercise anaerobic threshold and ventilatory efficiency identify heart failure patients for high risk of early death. Circulation. 2002;106:3079-3084.
28. Gatzoulis MA, Balaji S, Weber SA, et al. Risk factors for arrhythmia and sudden death late after repair of tetralogy of Fallot: a multicentre study. Lancet. 2000;356:975-981.